[ad_1]
Romania will continue vaccination with AstraZeneca, decided the representatives of the National Committee for the Coordination of Vaccination Activities against COVID-19 (CNCAV), the Ministry of Health, the National Institute of Public Health and the Romanian National Agency for Medicines and Health Products (ANMDMR) ). .
The decision was made by the representatives of these institutions after an extraordinary meeting in which the facts at the European level related to the vaccine produced by AstraZeneca were analyzed, after the report of cases of bleeding disorders in people immunized with this type of vaccine. .
“After the analysis of the reports of adverse reactions registered in Romania, the motivation for the decisions of other countries, the events reported internationally, but also the recommendations of the European regulatory authority, the European Medicines Agency (EMA), the representatives of the aforementioned institutions decided to continue the vaccination campaign in Romania with all the vaccines against COVID-19, currently authorized at the European level ”, is shown in a statement from the CNCAV.
Until the completion of the evaluation of the cases reported for blood clotting disorders by the Pharmacovigilance Committee of the European Medicines Agency (EMA), PRAC (Pharmacovigilance Risk Assessment Committee) and issue a recommendation at the extraordinary meeting that It will be held on Thursday, March 18 of this year. year., The EMA recommends continuing vaccination, emphasizing that the benefits of vaccination in preventing severe forms of COVID-19 and death outweigh the risk of side effects.
CNCAV: Cases of bleeding disorders have occurred in a small number of vaccinated patients
According to the CNCAV, cases of bleeding disorders occurred in a small number of vaccinated patients, without exceeding the frequency reported in the general unvaccinated population. It should be noted that these disorders have different causes and can occur regardless of the administration of the vaccine.
Currently, experts at the European level are analyzing with the utmost rigor all the available data to determine if there is a causal relationship between the administration of the vaccine and these events, ”according to CNCAV.
Vaccination remains the safe and effective solution to overcome the COVID-19 pandemic, and the vaccines used in Romania are authorized by the European Medicines Agency (EMA), the most rigorous decision-making body, which brings together experts to European level. We recommend reporting any suspected adverse reactions from both professionals and patients.
Which European countries have decided to discontinue the use of the AstraZeneca vaccine?
Germany, France, Italy and Spain have decided to discontinue use of AstraZeneca’s COVID-19 vaccine amid concerns about potential side effects of the vaccine.
The measures come after other European countries suspended vaccination with this serum due to suspicions related to the appearance of thrombosis in people immunized with it.
However, AstraZeneca said there is no scientific evidence linking vaccination with the serum produced by the company to an increased risk of thrombosis. The Anglo-Swedish company says, however, that all available safety data will be re-analyzed.
Editor: Mihnea Lazăr
